DK1480646T3 - Antiinfektiva og/eller immunomodulatorer til præventiv terapi efter akut slagtilfælde - Google Patents

Antiinfektiva og/eller immunomodulatorer til præventiv terapi efter akut slagtilfælde

Info

Publication number
DK1480646T3
DK1480646T3 DK03714776T DK03714776T DK1480646T3 DK 1480646 T3 DK1480646 T3 DK 1480646T3 DK 03714776 T DK03714776 T DK 03714776T DK 03714776 T DK03714776 T DK 03714776T DK 1480646 T3 DK1480646 T3 DK 1480646T3
Authority
DK
Denmark
Prior art keywords
infectives
immunomodulators
preventive therapy
acute stroke
agents
Prior art date
Application number
DK03714776T
Other languages
Danish (da)
English (en)
Inventor
Andreas Meisel
Konstantin Prass
Christian Meisel
Elke Halle
Ulrich Dirnagl
Hans Dieter Volk
Original Assignee
Charite Universitaetsmedizin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Charite Universitaetsmedizin filed Critical Charite Universitaetsmedizin
Application granted granted Critical
Publication of DK1480646T3 publication Critical patent/DK1480646T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24211—Parapoxvirus, e.g. Orf virus
    • C12N2710/24232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK03714776T 2002-03-05 2003-03-05 Antiinfektiva og/eller immunomodulatorer til præventiv terapi efter akut slagtilfælde DK1480646T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10210536 2002-03-05
DE10218328A DE10218328A1 (de) 2002-03-05 2002-04-24 Mittel zur präventiven Therapie nach akutem Schlaganfall
PCT/EP2003/002246 WO2003074057A1 (de) 2002-03-05 2003-03-05 Antiinfektiva und/oder immunnodulatoren zur präventiven therapie nach akutem schlaganfall

Publications (1)

Publication Number Publication Date
DK1480646T3 true DK1480646T3 (da) 2008-11-24

Family

ID=27789739

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03714776T DK1480646T3 (da) 2002-03-05 2003-03-05 Antiinfektiva og/eller immunomodulatorer til præventiv terapi efter akut slagtilfælde

Country Status (15)

Country Link
US (1) US8673934B2 (pt)
EP (1) EP1480646B1 (pt)
JP (1) JP2005525361A (pt)
CN (1) CN1652785A (pt)
AT (1) ATE402702T1 (pt)
AU (1) AU2003219016B2 (pt)
BR (1) BRPI0308256A2 (pt)
CA (1) CA2478133A1 (pt)
DE (2) DE10218328A1 (pt)
DK (1) DK1480646T3 (pt)
ES (1) ES2311093T3 (pt)
MX (1) MXPA04008573A (pt)
PT (1) PT1480646E (pt)
RU (1) RU2327454C2 (pt)
WO (1) WO2003074057A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005053679A1 (de) * 2005-06-24 2006-12-28 Bayer Healthcare Ag Therapeutischer Einsatz von Moxifloxacin zur Rekonstruktion von Funktionsstörungen des Immunsystems
DE102007020152A1 (de) * 2007-04-26 2008-10-30 Charité - Universitätsmedizin Berlin Mittel zur antiinfektiven Behandlung eines Patienten
US9598488B2 (en) * 2008-02-01 2017-03-21 Albany Medical College Blockage of interferon-gamma for prevention of polymicrobial synergy
RU2571282C1 (ru) * 2014-05-22 2015-12-20 Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт особо чистых биопрепаратов" Федерального медико-биологического агентства Способ лечения инсульта
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
CN110964778B (zh) * 2018-09-29 2024-02-23 南方医科大学珠江医院 肠杆菌科作为缺血性脑卒中生物标志物的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4437868A1 (de) * 1994-10-22 1996-04-25 Boehringer Ingelheim Int Behandlung von HLA-DR-assoziierter Immundefizienz mit Interferon-gamma
CN1194828A (zh) * 1998-04-22 1998-10-07 王卫东 具有协同作用的美洛西林和舒巴坦的药物组合物
DE19937116A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
DE60026618T2 (de) * 1999-12-30 2007-01-18 Intermune, Inc., Brisbane Gamma-ifn flüssigtropfenaerosol und verfahren

Also Published As

Publication number Publication date
US8673934B2 (en) 2014-03-18
JP2005525361A (ja) 2005-08-25
AU2003219016B2 (en) 2008-10-16
CA2478133A1 (en) 2003-09-12
CN1652785A (zh) 2005-08-10
MXPA04008573A (es) 2005-09-08
DE50310242D1 (de) 2008-09-11
RU2327454C2 (ru) 2008-06-27
ATE402702T1 (de) 2008-08-15
RU2004129591A (ru) 2005-09-20
US20050234089A1 (en) 2005-10-20
WO2003074057A1 (de) 2003-09-12
EP1480646A1 (de) 2004-12-01
PT1480646E (pt) 2008-11-03
EP1480646B1 (de) 2008-07-30
AU2003219016A1 (en) 2003-09-16
BRPI0308256A2 (pt) 2016-06-21
ES2311093T3 (es) 2009-02-01
WO2003074057A8 (de) 2005-09-29
DE10218328A1 (de) 2003-09-25

Similar Documents

Publication Publication Date Title
MX2021012589A (es) Derivados de piperidina como inhibidores de proteasa especifica de ubiquitina 7.
NO20005224L (no) BTK inhibitorer og fremgangsmåter for deres identifikasjon og anvendelse
CL2007001996A1 (es) Compuestos derivados de heteroarilos nitrogenados sustituidos con fenilo, inhibidores de la produccion de citoquinas; composicion farmaceutica que los comprende; y sus usos en el tratamiento del cancer, infecciones, enfermedades inflamatorias y autoinmunes.
NO20050795L (no) Forbindelser, blandinger og fremgangsmater for utnyttelse av samme
NO20074807L (no) Fast farmasoytisk doseringsformulering
BR0316170A (pt) Combinação, composição farmacêutica, uso de uma combinação, e, método para a profilaxia ou tratamento sinergìstico de câncer
CL2008001782A1 (es) Uso de una composicion que comprende un compuesto derivado de heterociclo para tratar o prevenir la perdida de flujo intestinal; composicion que comprende dicho compusto; y kit que comprende la composicion.
EP3938369A4 (en) TYK2 INHIBITORS AND USES THEREOF
EP3914357A4 (en) TYK2 INHIBITORS AND THEIR USES
BRPI0416268A (pt) composições de delta-9-thc e métodos para o tratamento de sintomas associados à esclerose múltipla
DK1635783T3 (da) Farmaceutiske præparater omfattende fentanyl til intranasal levering
NO20042719L (no) Substituerte 2-amino-cykloalkankarboksamider og deres anvendelse som protease-inhibitorer
BR112022021381A2 (pt) Compostos para o tratamento de sars
IL291080A (en) Systems, methods, and compounds for early and rapid detection of infection by host RNA biomarkers and early detection of covid-19 infection in humans
PH12020500569A1 (en) Influenza virus vaccines and uses thereof
MX2022014161A (es) Vacunas contra sars-cov-2.
DK1480646T3 (da) Antiinfektiva og/eller immunomodulatorer til præventiv terapi efter akut slagtilfælde
NO20035328D0 (no) Nye forbindelser og preparater som katepsinhibitorer
NO20062229L (no) Middel og fremgangsmate for a behandle cancer omfattende strontium, aminosyre(r) og mineralagent(er)
NO20043393L (no) Identifisering av objekter for levering.
BRPI0411168A (pt) composição para o tratamento dos cabelos, usos de uma composição e método de tratamento dos cabelos
ATE412014T1 (de) Immunmodulatorische konstrukte und deren verwendungen
IL309182A (en) Protease inhibitors for the treatment of corona virus infections
IL310209A (en) ROCK2 inhibitors and their uses
BR112022020295A2 (pt) Compostos para o tratamento de sars